HR 7050 119th Congress House In Committee

Homeopathic Drug Product Safety, Quality, and Transparency Act

Latest action: Referred to the House Committee on Energy and Commerce. · Jan 14, 2026

View full text on Congress.gov ↗ Policy area: Health

Sponsor
Rep. Sessions, Pete [R-TX-17]
Independent · TX
Cosponsors (4)
Rep. KennedyRep. JacksonRep. OwensRep. Mills

Track HR 7050 in BallotBox360

Get real-time bill updates, floor vote alerts, and AI-powered summaries — all in one app.

Download on iOS Open Web App